Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
TauTona Group, established in 2010 by two professors from the Stanford School of Medicine, operates from Redwood City, California. This vertically-integrated operational fund focuses on creating and developing solutions in medtech, biotech, and regenerative medicine. Their approach aims to address unmet clinical needs in healthcare.
TauTona Group invests in pre-seed, seed, and Series A stages, specifically targeting healthcare and biotech sectors. They emphasize a sustainable investment model that supports the evaluation, design, testing, and development of medical technologies. Their differentiated development process aims to de-risk projects from ideation to commercialization.
Notable products developed by TauTona Group include Pneumoperitoneum Assist Device (TPAD), BioBolt Surgical Stapler, and TauTona Wound Dressing (TWD).
Submit your pitch through their website contact form for consideration.
Yes, TauTona Group often leads investment rounds, particularly in the early stages of development.
TauTona Group is open to follow-on investments, especially for projects that show significant progress and potential for commercialization.
The specific size of TauTona Group's current fund is not publicly disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.